The European Summit on Pharma and Biotech Patent Litigation will be back in January 2023 for 3 days of practical discussion around the leading industry topics. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst also maximising your litigation strategy to allow for successful IP protection.
At this event, you will network with leading figures in the industry and gain unique insights on the latest regulatory changes and case-law updates. This makes it a must-attend event for anyone working within the life sciences IP industry.
Highlights Include:
- The impact of the SPC Referral Cases and the uptake of the Manufacturing Waiver with Heidi Adler (Orion Corporation), James Horgan (MSD) and Robin Ellis (Reddie & Grose).
- Transatlantic understanding of Biologics Patent Litigation with topics such as: biosimilar launches, section 112 and sufficiency of disclosure with Julia Pike (Sandoz), Mike Cottler (Alvotech) and Robert Cerwinski (Gemini Law).
- Examine recent case law in Europe on preliminary injunctions and assess how the decisions affect your litigation strategy with Jenny Davies (Gowling WLG), Peter Meier-Beck (UPC Advisory Committee), Sara Burghart (Sandoz), and Gerben Hartman (CJEU).
Event Name: Pharma & Biotech Patent Litigation Europe
Event Venue: Anantara Grand Hotel Krasnapolsky Amsterdam Dam 9, 1012 Js Amsterdam, Netherlands
Event Date: 24-25 January, 2023
Event website: https://hubs.ly/Q01sH8Jz0
Event Organizer: Kisaco Research
Contact number: +44 20 3696 2920
Email ID: events@kisacoresearch.com
Social Media Link 1: https://www.linkedin.com/company/legal-and-compliance-hub/
Social Media Link 2: https://twitter.com/KisacoLegalHub?s=20&t=npHLZ13YbrAo1ShWOQOR6Q
